文献速递重症综合管理与镇静镇痛

护士主导的家庭参与支持干预对ICU患者临床结局的影响:一项前瞻性准实验研究

Nurse-led family participatory support intervention on clinical outcomes in ICU patients: a prospective quasi-experimental study.
PubMed 文献 · Crit Care · 2026-06-18
一句话结论护士主导的家庭参与支持干预可降低危重成人患者谵妄发生率(26.85% vs 34.25%),并缩短机械通气、ICU及住院时间,不增加不良事件。

该研究在甘肃省三家三级医院ICU开展前瞻性准实验研究,纳入危重成人患者,分为护士主导的家庭参与支持(NFPS)组与无家庭参与的常规护理(non-NFPS)组,经1:1倾向性评分匹配后每组365例。NFPS组谵妄发生率显著降低(26.85% vs 34.25%,P=0.03),住院时间、ICU住院时间、机械通气时间均显著缩短,住院费用更低。6个月死亡率、1年死亡率、ICU获得性衰弱、ICU获得性感染及不良事件两组无显著差异。结果表明NFPS可减少谵妄并改善部分临床结局,且未增加风险。

要点

  • 经1:1倾向性评分匹配后每组365例,NFPS组谵妄发生率26.85% vs 常规护理组34.25%(P=0.03),显著降低。
  • NFPS组住院时间25[17-34]天 vs 对照组30[22-38]天(P<0.001),ICU住院时间13[7-17]天 vs 14[10-18]天(P<0.001)。
  • NFPS组机械通气时间10[6-15]天 vs 对照组11[8-17]天(P<0.001),住院费用193,931.99[117,616.64-294,201.02]元 vs 199,330.72[138,636.05-300,993.88]元(P=0.032)。
  • 6个月死亡率(6.03% vs 7.67%,P=0.380)和1年死亡率(9.32% vs 11.51%,P=0.330)两组无显著差异。
  • ICU获得性衰弱(26.58% vs 29.59%,P=0.270)、ICU获得性感染(19.45% vs 19.73%,P=0.930)及不良事件(2.19% vs 3.84%,P=0.190)两组无显著差异。

适用人群与场景

  • 甘肃省三家三级医院ICU收治的危重成人患者。
  • NFPS组由经过培训的家庭成员在ICU护士指导下参与护理;对照组为无家庭参与的常规护理。

处置流程与药物剂量

  • NFPS组:经过培训的家庭成员在ICU护士指导下参与患者护理。
  • 对照组:接受无家庭参与的常规护理。

研究设计与关键结果

  • 研究类型:前瞻性准实验研究;纳入甘肃省三家三级医院ICU的危重成人患者,经1:1倾向性评分匹配后每组365例。
  • 主要终点:NFPS组谵妄发生率26.85% vs 对照组34.25%(P=0.03),显著降低。
  • 次要终点:住院时间25[17-34]天 vs 30[22-38]天(P<0.001);ICU住院时间13[7-17]天 vs 14[10-18]天(P<0.001);机械通气时间10[6-15]天 vs 11[8-17]天(P<0.001);住院费用193,931.99[117,616.64-294,201.02]元 vs 199,330.72[138,636.05-300,993.88]元(P=0.032)。
  • 6个月死亡率6.03% vs 7.67%(P=0.380),1年死亡率9.32% vs 11.51%(P=0.330),ICU获得性衰弱26.58% vs 29.59%(P=0.270),ICU获得性感染19.45% vs 19.73%(P=0.930),不良事件2.19% vs 3.84%(P=0.190),均无显著差异。

证据类型、等级与局限

  • 证据类型:前瞻性准实验研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为NFPS可显著降低谵妄发生率,并缩短机械通气时间、ICU住院时间和总住院时间,降低住院费用,且不增加ICU获得性衰弱、ICU获得性感染或不良事件风险;两组长期死亡率无显著差异。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Delirium is a common and serious complication in critically ill patients, and family-centered care has emerged as a promising non-pharmacological strategy. However, evidence on structured, nurse-led family participatory support (NFPS) intervention remains limited.

AIM: To evaluate the effectiveness and safety of NFPS in critically ill adult patients.

METHODS: Adult patients admitted to intensive care units (ICU) from three tertiary hospitals in Gansu Province were allocated to either the NFPS group or a usual care group without family participation (non-NFPS). In the NFPS group, trained family members participated in care under the guidance of ICU nurses. The primary outcome was the incidence of delirium.

RESULTS: After 1:1 propensity score matching, 365 patients were included in each group. The NFPS group demonstrated significant reductions in incidence of delirium [26.85% vs. 34.25%, p = 0.03]. Compared with the control group, the NFPS group also had significantly shorter hospital length of stay (HLOS) (25 [17-34] vs. 30 [22-38] days, P < 0.001), ICU-LOS (13 [7-17] vs. 14 [10-18] days, P < 0.001), duration of mechanical ventilation (10 [6-15] vs. 11 [8-17] days, P < 0.001) and lower hospitalization cost (193,931.99 [117,616.64-294,201.02] vs. 199,330.72 [138,636.05-300,993.88] CNY, P = 0.032). No significant differences were observed in 6-month mortality (6.03% vs. 7.67%, P = 0.380), 1-year mortality (9.32% vs. 11.51%, P = 0.330), ICU-acquired weakness (26.58% vs. 29.59%, P = 0.270), ICU-acquired infection (19.45% vs. 19.73%, P = 0.930), or adverse events (2.19% vs. 3.84%, P = 0.190).

CONCLUSION: The NFPS significantly reduced the incidence of delirium and was associated with shorter durations of mechanical ventilation, ICU-LOS, HLOS, lower hospitalization costs, without increasing the risks of ICU-AW, ICU-acquired infection, or adverse events. No significant differences were observed in long-term mortality between the two groups.

来源:Crit Care,查看原文。版权归原作者所有。

参考来源

  1. Wu Y, Wang G, Mu K, et al. Nurse-led family participatory support intervention on clinical outcomes in ICU patients: a prospective quasi-experimental study. Crit Care. 2026. PMID: 42316318. doi:10.1186/s13054-026-06145-z

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。